Females Exhibit Higher GluA2 Levels and Outperform Males in Active Place Avoidance Despite Increased Amyloid Plaques in TgF344-Alzheimer's Rats

Overview

Journal Sci Rep

Specialty Science

Date 2022 Nov 9

PMID 36352024

Authors

Osama Chaudry

Kelechi Ndukwe

Lei Xie

Maria Figueiredo-Pereira

Peter Serrano

Patricia Rockwell

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease that is most prevalent in females. While estrogen provides neuroprotection in females, sex mediated differences in the development of AD pathology are not fully elucidated. Therefore, comparing events between sexes in early-stage AD pathology may reveal more effective therapeutic targets of intervention. To address sex differences, we analyzed early-stage 9-month male and female TgF344-AD (Tg-AD) rats, an AD model carrying the APPswe and Presenilin 1 (PS1ΔE9) mutations that develops progressive age-dependent AD pathology similar to humans. Tg-AD females significantly outperformed Tg-AD males in the active place avoidance (aPAT) test that assesses hippocampal-dependent spatial learning and memory. However, comparisons between Tg-AD male or female rats and their WT counterparts showed significant deficits for female but not male rats. Nevertheless, Tg-AD females experienced significantly less hippocampal neuronal loss with higher GluA2 subunit levels than Tg-AD males. Unexpectedly, Tg-AD females displayed higher levels of hippocampal amyloid plaques than Tg-AD males. Thus, we propose that GluA2 may provide a neuroprotective function for Tg-AD females in our rat model by mitigating cognitive impairment independently of amyloid plaques. Elucidating this protective mechanism in AD could lead to new targets for early intervention.

Citing Articles

Quantification and correlation of amyloid-β plaque load, glial activation, GABAergic interneuron numbers, and cognitive decline in the young TgF344-AD rat model of Alzheimer's disease.

Futacsi A, Rusznak K, Szarka G, Volgyi B, Wiborg O, Czeh B Front Aging Neurosci. 2025; 17:1542229.

PMID: 40013092 PMC: 11860898. DOI: 10.3389/fnagi.2025.1542229.

rTCT: Rodent Triangle Completion Task to facilitate translational study of path integration.

Duncan S, Rehman S, Sagen V, Choi I, Lawrence S, Kalani O bioRxiv. 2025; .

PMID: 39975325 PMC: 11838589. DOI: 10.1101/2025.02.04.636463.

Nodal degree centrality in the default mode-like network of the TgF344-AD Alzheimer's disease rat model as a measure of early network alterations.

Amiri S, van den Berg M, Nazem-Zadeh M, Verhoye M, Amiri M, Keliris G NPJ Aging. 2024; 10(1):29.

PMID: 38902224 PMC: 11190202. DOI: 10.1038/s41514-024-00151-7.

Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model.

Fongsaran C, Jirakanwisal K, Peng B, Fracassi A, Taglialatela G, Dineley K Brain Behav Immun Health. 2024; 38:100780.

PMID: 38706571 PMC: 11067009. DOI: 10.1016/j.bbih.2024.100780.

Early altered directionality of resting brain network state transitions in the TgF344-AD rat model of Alzheimer's disease.

De Waegenaere S, van den Berg M, Keliris G, Adhikari M, Verhoye M Front Hum Neurosci. 2024; 18:1379923.

PMID: 38646161 PMC: 11026683. DOI: 10.3389/fnhum.2024.1379923.

References

Cohen R, Rezai-Zadeh K, Weitz T, Rentsendorj A, Gate D, Spivak I . A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss. J Neurosci. 2013; 33(15):6245-56. PMC: 3720142. DOI: 10.1523/JNEUROSCI.3672-12.2013. View

Sheng J, Zhou X, Mrak R, Griffin W . Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease. J Neuropathol Exp Neurol. 1998; 57(7):714-7. PMC: 3833627. DOI: 10.1097/00005072-199807000-00008. View

Bi D, Wen L, Wu Z, Shen Y . GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease. Alzheimers Dement. 2020; 16(9):1312-1329. DOI: 10.1002/alz.12088. View

Harrison F, Hosseini A, McDonald M . Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks. Behav Brain Res. 2008; 198(1):247-51. PMC: 2663577. DOI: 10.1016/j.bbr.2008.10.015. View

Meda L, Cassatella M, Szendrei G, Otvos Jr L, Baron P, Villalba M . Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 1995; 374(6523):647-50. DOI: 10.1038/374647a0. View

Rodriguez-Ortiz C, Prieto G, Martini A, Forner S, Trujillo-Estrada L, LaFerla F . miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease. Aging Cell. 2020; 19(3):e13118. PMC: 7059142. DOI: 10.1111/acel.13118. View

Soltys Z, Ziaja M, Pawlinski R, Setkowicz Z, Janeczko K . Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methods. J Neurosci Res. 2001; 63(1):90-7. DOI: 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9. View

Bazzigaluppi P, Beckett T, Koletar M, Lai A, Joo I, Brown M . Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease. J Neurochem. 2017; 144(5):669-679. DOI: 10.1111/jnc.14136. View

Tonnies E, Trushina E . Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease. J Alzheimers Dis. 2017; 57(4):1105-1121. PMC: 5409043. DOI: 10.3233/JAD-161088. View

10.

Sebastian V, Vergel T, Baig R, Schrott L, Serrano P . PKMζ differentially utilized between sexes for remote long-term spatial memory. PLoS One. 2013; 8(11):e81121. PMC: 3823701. DOI: 10.1371/journal.pone.0081121. View

11.

Jha S, Jha N, Kumar D, Sharma R, Shrivastava A, Ambasta R . Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer's Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?. J Alzheimers Dis. 2016; 57(4):1017-1039. DOI: 10.3233/JAD-160623. View

12.

Keith D, El-Husseini A . Excitation Control: Balancing PSD-95 Function at the Synapse. Front Mol Neurosci. 2008; 1:4. PMC: 2526002. DOI: 10.3389/neuro.02.004.2008. View

13.

Das Sarma J . Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology. J Neurovirol. 2013; 20(2):122-36. DOI: 10.1007/s13365-013-0188-4. View

14.

Oliveros G, Wallace C, Chaudry O, Liu Q, Qiu Y, Xie L . Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. Brain. 2022; 146(3):898-911. PMC: 10226755. DOI: 10.1093/brain/awac136. View

15.

Mielke M . Sex and Gender Differences in Alzheimer's Disease Dementia. Psychiatr Times. 2019; 35(11):14-17. PMC: 6390276. View

16.

Gao L, Tian M, Zhao H, Xu Q, Huang Y, Si Q . TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease. J Neurochem. 2015; 136(3):620-36. DOI: 10.1111/jnc.13432. View

17.

Hemonnot A, Hua J, Ulmann L, Hirbec H . Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities. Front Aging Neurosci. 2019; 11:233. PMC: 6730262. DOI: 10.3389/fnagi.2019.00233. View

18.

Nilsen J, Chen S, Irwin R, Iwamoto S, Brinton R . Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci. 2006; 7:74. PMC: 1636062. DOI: 10.1186/1471-2202-7-74. View

19.

Perlmutter L, Barron E, Chui H . Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett. 1990; 119(1):32-6. DOI: 10.1016/0304-3940(90)90748-x. View

20.

Yeung J, Walby J, Palpagama T, Turner C, Waldvogel H, Faull R . Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex. Brain Pathol. 2021; 31(6):e13005. PMC: 8549033. DOI: 10.1111/bpa.13005. View